Background: Non-invasive facial treatments have the ability to rejuvenate the facial profile when specific pharmacologic agents and modalities are prescribed and used in combination taking into consideration each pati...Background: Non-invasive facial treatments have the ability to rejuvenate the facial profile when specific pharmacologic agents and modalities are prescribed and used in combination taking into consideration each patient’s unique skin type and condition. RATIONALE Epinova is a non-invasive skin treatment that combines the correct concentrations and combinations of topicals and modalities to elicit facial rejuvenation with no down-time or side effects. Purpose: This paper focuses on facial rejuvenation improvements combining the RATIONALE Essential Six skincare system (RATIONALE, Victoria, Australia) to protect and repair the skin with the RATIONALE Epinova facial treatment every 4-6 weeks—which uses non-invasive technologies and professional strength active ingredients to deliver visible changes to skin tone and texture. Methods: Subjects underwent a RATIONALE consultation, including taking a skin history and skin imaging, followed by a data analysis and diagnosis of skin condition and prescription of a customized RATIONALE treatement (Epinova), including appropriate pharmacologic agents and treatment with personalized photo/sono therapeutic devices. Results: Subjects reported increased skin hydration, tactile improvements, skin firmness and visible radiance following the RATIONALE Epinova treatment. Further investigations will be initiated to explore the potential for longer term improvements, including connenctive tissue deposition, reduction of erythema etc. Treatments should be performed every 4-6 weeks for patients under 40 and every 3-4 weeks for patients over 40, to support cell differentiation, migration and desquamation to achieve non-invasive facial rejuvenation. Conclusion: This study demonstrated that the synergy of pharmacologic, LED light therapy and ultrasonic technologies when prescribed and administered by a trained skin therapist, can lead to a visible improvement in the signs of facial ageing and photodamage, restoring the appearance of healthy, radiant skin. .展开更多
目的:探讨无创皮肤吻合器联合心形缝合皮下脂肪对腹部瘢痕的影响。方法:回顾性分析2021年1月—2022年9月于新余市妇幼保健院行剖宫产手术的120例患者的病历资料,将接受无创皮肤吻合器联合心形缝合的60例患者纳入A组,将接受无创皮肤吻合...目的:探讨无创皮肤吻合器联合心形缝合皮下脂肪对腹部瘢痕的影响。方法:回顾性分析2021年1月—2022年9月于新余市妇幼保健院行剖宫产手术的120例患者的病历资料,将接受无创皮肤吻合器联合心形缝合的60例患者纳入A组,将接受无创皮肤吻合器联合传统美容缝合的60例患者纳入B组,两组出院后均随访6个月。比较两组切口缝合时间、切口愈合时间及住院时间,术后24 h、72 h、7 d切口疼痛[视觉模拟评分法(VAS)],术后1个月切口愈合情况、切口并发症发生率,术后6个月切口瘢痕情况[温哥华瘢痕评定量表(VSS)]、缝合效果满意度。结果:两组切口缝合时间差异无统计学意义(P>0.05),A组切口愈合时间与住院时间均短于B组,差异均有统计学意义(P<0.05);两组术后24 h、72 h VAS评分差异均无统计学意义(P>0.05),A组术后7 d VAS评分低于B组,差异有统计学意义(P<0.05);术后1个月,A组伤口愈合等级优于B组,A组切口并发症总发生率低于B组,差异均有统计学意义(P<0.05);术后6个月,A组VSS评分低于B组,A组缝合效果满意度高于B组,差异均有统计学意义(P<0.05)。结论:无创皮肤吻合器联合心形缝合皮下脂肪在剖宫产患者中应用价值高,能有效促进术后患者腹部切口愈合,减少术后疼痛,降低切口并发症发生及瘢痕增生风险,并获得更高的患者满意度。展开更多
文摘Background: Non-invasive facial treatments have the ability to rejuvenate the facial profile when specific pharmacologic agents and modalities are prescribed and used in combination taking into consideration each patient’s unique skin type and condition. RATIONALE Epinova is a non-invasive skin treatment that combines the correct concentrations and combinations of topicals and modalities to elicit facial rejuvenation with no down-time or side effects. Purpose: This paper focuses on facial rejuvenation improvements combining the RATIONALE Essential Six skincare system (RATIONALE, Victoria, Australia) to protect and repair the skin with the RATIONALE Epinova facial treatment every 4-6 weeks—which uses non-invasive technologies and professional strength active ingredients to deliver visible changes to skin tone and texture. Methods: Subjects underwent a RATIONALE consultation, including taking a skin history and skin imaging, followed by a data analysis and diagnosis of skin condition and prescription of a customized RATIONALE treatement (Epinova), including appropriate pharmacologic agents and treatment with personalized photo/sono therapeutic devices. Results: Subjects reported increased skin hydration, tactile improvements, skin firmness and visible radiance following the RATIONALE Epinova treatment. Further investigations will be initiated to explore the potential for longer term improvements, including connenctive tissue deposition, reduction of erythema etc. Treatments should be performed every 4-6 weeks for patients under 40 and every 3-4 weeks for patients over 40, to support cell differentiation, migration and desquamation to achieve non-invasive facial rejuvenation. Conclusion: This study demonstrated that the synergy of pharmacologic, LED light therapy and ultrasonic technologies when prescribed and administered by a trained skin therapist, can lead to a visible improvement in the signs of facial ageing and photodamage, restoring the appearance of healthy, radiant skin. .
文摘目的:探讨无创皮肤吻合器联合心形缝合皮下脂肪对腹部瘢痕的影响。方法:回顾性分析2021年1月—2022年9月于新余市妇幼保健院行剖宫产手术的120例患者的病历资料,将接受无创皮肤吻合器联合心形缝合的60例患者纳入A组,将接受无创皮肤吻合器联合传统美容缝合的60例患者纳入B组,两组出院后均随访6个月。比较两组切口缝合时间、切口愈合时间及住院时间,术后24 h、72 h、7 d切口疼痛[视觉模拟评分法(VAS)],术后1个月切口愈合情况、切口并发症发生率,术后6个月切口瘢痕情况[温哥华瘢痕评定量表(VSS)]、缝合效果满意度。结果:两组切口缝合时间差异无统计学意义(P>0.05),A组切口愈合时间与住院时间均短于B组,差异均有统计学意义(P<0.05);两组术后24 h、72 h VAS评分差异均无统计学意义(P>0.05),A组术后7 d VAS评分低于B组,差异有统计学意义(P<0.05);术后1个月,A组伤口愈合等级优于B组,A组切口并发症总发生率低于B组,差异均有统计学意义(P<0.05);术后6个月,A组VSS评分低于B组,A组缝合效果满意度高于B组,差异均有统计学意义(P<0.05)。结论:无创皮肤吻合器联合心形缝合皮下脂肪在剖宫产患者中应用价值高,能有效促进术后患者腹部切口愈合,减少术后疼痛,降低切口并发症发生及瘢痕增生风险,并获得更高的患者满意度。
